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Effects of alpha lipoic acid and vitamin C supplementation on transforming
growth factor alpha (TGF α) and transforming growth factor beta 2 (TGF β2)
secretion in testicular tissue of diabetic rats*
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Abstract: The effects of alpha lipoic acid and vitamin C supplementation on TGF α and TGF β2 secretion in the testicular tissue
of streptozotocin-induced diabetic rats were examined by immunohistochemical methods. Rats were divided into 5 groups; group 1
(control), 2 (diabetic control), 3 (diabetes + alpha lipoic acid), 4 (diabetes + vitamin C), and 5 (diabetes + alpha lipoic acid + vitamin
C). Hematoxylin and eosin staining was performed in order to examine testicular tissue histopathologically. The streptavidin-biotinperoxidase complex method was used for histological examination and determination of TGF α and TGF β2 localization in the testicular
tissue. Regarding fasting blood glucose levels, the lowest blood glucose level was detected in group 3. Fewer pathological histopathological
findings were observed in groups treated with alpha lipoic acid, vitamin C, and alpha lipoic acid + vitamin C compared to the diabetes
group. TGF α and TGF β2 secretions increased in groups 3, 4, and 5 compared to group 2. In conclusion, exogenous administration of
alpha lipoic acid, vitamin C, and alpha lipoic acid + vitamin C increased TGF α and TGF β2 secretion in streptozotocin-induced diabetic
rats.
Key words: Alpha lipoic acid, diabetes, vitamin C, TGF α, TGF β2

1. Introduction
Diabetes mellitus (DM) is a degenerative disease causing
alterations in carbohydrate homeostasis that, in turn, affect
the function of the male reproductive system (1). DM is
divided into 2 groups, type I and type II. Type I diabetes is
caused by lack of insulin secretion. Type II diabetes is due
to increased insulin resistance or lack of insulin receptors
in target tissues (2).
Oxidative stress increases in diabetes due to
overproduction of reactive oxygen species (ROS) and
decreased efficiency of antioxidant defenses (3). To control
the flux of ROS, aerobic cells have developed an antioxidant
defense system with enzymatic and nonenzymatic
components (4). Common antioxidants include vitamins A,
C, and E; glutathione; superoxide dismutase, catalase, and
glutathione peroxidase enzymes; and several bioflavonoids
that fight against different types of free radicals in synergy (5).

Alpha lipoic acid (ALA) is one of the antioxidants
that is effective in all steps of the antioxidant defense
system such as inhibiting radical metabolite production,
scavenging generated radicals, repairing resulting cell
damage, halting chain reactions producing secondary
radicals, and maximizing endogenous antioxidant capacity
(6). ALA is synthesized in the liver, heart, and kidney
tissues of humans (7).
Vitamin C, also known as ascorbic acid, is an important
antioxidant in biological systems, with molecular formula
C6H8O6 and greyish white color. As humans are unable to
synthesize vitamin C, they need this vitamin in their diet
(8).
Transforming growth factor α (TGF α) is a member
of the EGF family of cytokines that are synthesized as
transmembrane precursors and characterized by the
presence of one or several EGF structural units in their
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extracellular domain (9). TGF α exerts identical biological
effects on proliferation, differentiation, and differentiated
function in a wide variety of target cells (10).
Transforming growth factor β (TGF β) is formed by
inactive peptide dimers with 25 kDa molecular weights
and is widely expressed in the mammalian body (11,12).
TGF β family has 3 members, TGF β1, TGF β2, and TGF β3
(13). This family regulates numerous biological activities,
including cell proliferation, differentiation, adhesion,
apoptosis, extracellular matrix (ECM) production, and
early embryo development and immunity (14).
The present study investigated the effects of ALA
and vitamin C supplementation on TGF α and TGF
β2 secretion, which have antioxidant and growth,
development, differentiation, and also regulatory
properties, respectively, in testicular tissues of rats with
diabetes by immunohistochemical methods.
2. Materials and methods
2.1. Animals and care conditions
This study was approved by the Mehmet Akif Ersoy
University Local Ethics Committee for Animal Experiments
under the 12/03/2014, 11/68 protocol number.
At the beginning of the experiment 50 male Sprague–
Dawley rats (310–365 g, 4–5 months old) were randomly
divided into 5 groups of 10 animals each. The rats were kept
in standard cages at 22 ± 2 °C and were exposed to a 12-h
light cycle. Administrations were started after a 1-week
adaptation period and were made each day between 1700
and 1800.
2.2. Experimental design
Group 1 (control) (n = 10): animals were fed ad
libitum, group 2 (diabetes control) (n = 10): 50 mg/kg
streptozotocin (STZ) dissolved in 50 mL of citric acid +
40 mL of disodium hydrogen phosphate buffer (pH 4.5)
was administered intraperitoneally (ip). In order to ensure
uniform group standards, saline was given by oral gavage
to the animals throughout the study. Three days after STZ
administration, fasting blood glucose levels of tail vein
blood of rats fasted 8 h were measured by glucometer, and
animals with fasting blood glucose of 250 mg/dL were
labeled type I diabetic. Group 3 (diabetes + alpha lipoic
acid) (n = 10): diabetic rats, as a result of administration
of 50 mg/kg ip of STZ, were given 80 mg/kg of alpha lipoic
acid orally for 21 days. Group 4 (diabetes + vitamin C) (n =
10): diabetic rats, as a result of administration of 50 mg/kg
ip of STZ, were given 60 mg/kg of vitamin C orally for 21
days. Group 5 (diabetes + alpha lipoic acid + vitamin C) (n
= 10): diabetic rats, as a result of administration of 50 mg/
kg ip of STZ, were given 80 mg/kg of alpha lipoic acid and
60 mg/kg of vitamin C orally for 21 days.

2.3. Body weights
Live body weights of rats in all groups were measured
before and after the experimental period. All rats were
sacrificed by cervical dislocation under diethyl ether
anesthesia, and then testicular tissue samples were taken.
Statistical Package for the Social Sciences 18.0 (SPSS)
software was used to compare variants among groups.
Possible differences were determined by using ANOVA
and Tukey’s test. The confidence interval in statistical
analysis was P < 0.05.
2.4. Determination of blood glucose levels
Before starting the study (day 0), the animals were fasted
for 8 h, venous blood samples were taken from tail veins,
and a glucometer (Yasee, GLM-76, Taiwan) was used for
determination of fasting blood glucose levels. Three days
after STZ administration, fasting blood glucose levels
of tail vein blood of rats fasted 8 h were measured, and
animals with fasting blood glucose of 250 mg/dL were
included in the study. Similarly, blood glucose levels
were measured on days 10, 17, and 24 of the study
following 8 h of fasting. Starting from the third day of STZ
administration, ALA and vitamin C were administered
orally to the experimental groups for 21 days.
2.5. Histopathology
Testicular tissue samples were fixed in 10% formaldehyde
for 24 h and processed routinely for embedment in
paraffin. Then, 5-µm thick serial sections were obtained
and stained with hematoxylin and eosin (H&E), following
deparaffinization and rehydrating, to demonstrate the
general structure of the testis.
2.6. Immunohistochemistry
For immunohistochemical staining, the streptavidinbiotin-peroxidase complex method was utilized on 5-µm
thick sections. After deparaffinization and rehydration of
the sections, endogenous peroxidase activity was blocked
with 0.3% hydrogen peroxide for 20 min. Then the
sections were washed in 0.01 M phosphate buffered saline
(PBS) solution, pH 7.4. The tissue sections were incubated
with polyclonal rabbit anti-TGF α (cat. no. GF10; Merck,
USA) and polyclonal goat anti- TGF β (sc-90; Santa Cruz,
CA, USA) diluted 1:100 in PBS. Sections were incubated
with biotinylated goat anti-rabbit and rabbit anti-goat
IgG for 30 min and peroxidase conjugated streptavidin
(1:300) (P0397; Dako Corp., Carpinteria, CA, USA) for
30 min. Broad spectrum antibody [Invitrogen Histostain
Plus Broad Spectrum (AEC), ref. 85.9943] was used as
chromogen followed by hematoxylin counterstaining.
Sections were mounted with Immuno Mount and examined
under light microscopy (Olympus BX51; Shinjuku, Tokyo,
Japan). Rabbit serum without primer antibody served as
negative control. TGF α and TGF β-2 staining intensities
were judged as (–) negative; (+) slight; (++) moderate, and
(+++) intense immunolabeling.
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3. Results
3.1. Blood glucose levels
On the starting day (day 0), blood glucose levels of the
groups were between 64 and 100 mg/dL. A significant
increase was observed in blood glucose levels of group 1
towards the end of the study (day 0 and 24th day, P < 0.01;
10th day and 24th day, P < 0.05) (Table 1).
Significant increases were detected in blood glucose
levels of all diabetic groups on day 3 (P < 0.001). Blood
glucose levels increased day by day in group 2. A
significant increase was detected on day 24 in group 4 (P <
0.001) (Table 1). Significant increases were found in blood
glucose levels of group 3 between days 3 and 17, 3 and 24,
10 and 17, and 10 and 24 at P < 0.001 level. In group 5, the
increase in glucose levels on day 24 compared to days 3
and 10 was significant (P < 0.05) (Table 2).
A significant decrease was determined in blood glucose
levels of group 4 compared to group 2 on day 17 (P < 0.01).
Nonsignificant decreases were detected in groups 3 and 5
on days 10 and 17, respectively (P > 0.05) (Table 2).
3.2. Body weight findings
Body weights of all groups were measured beginning on
the 3rd, 10th, 14th, and 24th days of the study, and groups
were evaluated within groups. A statistically nonsignificant

increase in body weights of the animals in group 1 was
observed (3rd day, 10th day, 17th day, and 24th day; P
> 0.05). A statistically significant decrease was observed
in body weights of group 2 animals (3rd day, 10th day,
17th day, and 24th day; P < 0.001). Measurement of the
body weights of group 3 revealed statistically significant
decreases on the 3rd day (P < 0.05), 10th day (P < 0.01),
17th day, and 24th day (P < 0.001). Similarly, statistically
significant changes were observed in the measurements of
group 4 with levels of P < 0.001 on days 3, 10, 17, and 24.
Statistically significant decreases at advanced levels were
determined in the weights of group 5 (3rd day, P < 0.05;
10th day, 17th day, and 24th day, P < 0.001) (Table 3).
3.3. Histopathological results
No difference was observed in the histological structure
of rats in group 1 (Figure 1a). In group 2, degenerative
and necrotic changes were observed in some seminiferous
tubules, Sertoli cells, and spermatogenetic cells. A
reduction in number of spermatogenetic cells and collapse
of seminiferous tubules due to necrosis were also observed
(Figure 1b). Results in groups 3 and 4 were similar to
those in group 1 (Figures 1c and 1d). In group 5 there
was a marked reduction in degenerative and necrotic
changes in seminiferous tubules and Sertoli cells and in
spermatogenesis (Figure 1e).

Table 1. Comparison of blood glucose levels in all groups (mg/dL).
Glucose

Day 0
X ± SD

3rd day
X ± SD

10th day
X ± SD

17th day
X ± SD

24th day
X ± SD

Group 1
Group 2
Group 3
Group 4
Group 5

84.8 ± 4.6b
83.9 ± 5.3c
83.2 ± 9.1c
83.4 ± 6.4c
86.9 ± 10.5c

86.5 ± 6.4b
307.8 ± 32.9b*
323.5 ± 30.3b*
311.8 ± 19.2b
329.6 ± 22.3b

88.0 ± 5.4b*
326.8 ± 26.1b†
316.6 ± 20.9b†
318.4 ± 50.1b
327.2 ± 16.9b

89.9 ± 6.7ab
377.5 ± 41.4a*
369.8 ± 17.3a*
311.1 ± 35.8b
344.1 ± 32.5ab

97.4 ± 10.2a
402.4 ± 19.7a†
393.5 ± 8.4a†
393.7 ± 5.9a
375.2 ± 57.0a

Different superscripts (a,b,c,*,†) in the same column indicate significant differences between groups. Group 1: a-b: P < 0.01; a-b*: P < 0.05.
Group 2: b*-c, b†-c, a*-c, a†-c, a*-b*, b*-a†, a†-b†: P < 0.001; b†-a*: P < 0.01. Group 3: b*-c, b†-c, a*-c, a†-c, a*-b*, a†-b*, a*-b†, a†-b†:
P < 0.001. Group 4: b-c, a-c, a-b: P < 0.001. Group 5: a-c, b-c, ab-c: P < 0.001; a-b: P < 0.05.
Table 2. Comparison of blood glucose levels among all groups (mg/dL).
Glucose

Group 1

Group 2

Group 3

Group 4

Group 5

Day 0 (X ± SD)
3rd day (X ± SD)
10th day (X ± SD)
17th day (X ± SD)
24th day (X ± SD)

84.8 ± 4.6
86.5 ± 6.4b
88.0 ± 5.4b
89.9 ± 6.7c
97.4 ± 10.2b

83.9 ± 5.3
307.8 ± 32.9a
326.8 ± 26.1a
377.5 ± 41.4a
402.4 ± 19.7a

83.2 ± 9.1
323.5 ± 30.3a
316.6 ± 20.9a
369.8 ± 17.3a
393.5 ± 8.4a

83.4 ± 6.4
311.8 ± 19.2a
318.4 ± 50.1a
331.1 ± 35.8b
393.7 ± 5.9a

86.9 ± 10.5
329.6 ± 22.3a
327.2 ± 16.9a
344.1 ± 32.5ab
375.2 ± 57.0a

Different superscripts (a,b,c ) in the same column indicate significant differences between groups. Day 0: P > 0.05; 3rd day: a-b: P < 0.001;
10th day: a-b: P < 0.001; 17th day: a-c, b-c, ab-c, a*-c: P < 0.001, a*-b: P < 0.01, a-b: P < 0.05; 24th day: a-b: P < 0.001.
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Table 3. The mean weight of rats in all groups among days (g).
Glucose

Day 0
X ± SD

3rd day
X ± SD

10th day
X ± SD

17th day
X ± SD

24th day
X ± SD

Group 1
Group 2
Group 3
Group 4
Group 5

365.4 ± 15.3
317.5 ± 8.0a
306.3 ± 12.8a
341.9 ± 5.1a
341.5 ± 9.0a

356.7 ± 37.7
281.4 ± 17.8b
276.7 ± 23.7b
310.8 ± 7.7b
308.7 ± 19.0b

366.3 ± 25.4
270.2 ± 18.1bc
268.3 ± 22.2bc
292.0 ± 14.6c
288.1 ± 24.9bc

381.6 ± 30.7
261.9 ± 19bc
248.9 ± 21.8c
278.2 ± 13cd
270.2 ± 25.8cd

390.6 ± 27.1
252.8 ± 20.2c
241.2 ± 24.4c*
270.9 ± 13.9d
244.6 ± 30.4d

Different superscripts (a,b,c) in the same column indicate significant differences between groups. Group 1: P > 0.05. Group 2: a-b, a-bc,
a-c: P < 0.001; b-c: P < 0.01. Group 3: a-c, a-c*: P < 0.001; a-bc, b-c*: P < 0.01; a-b, b-c: P < 0.05. Group 4: a-b, a-c, a-cd, a-d, b-cd, b-d,
c-d: P < 0.001; b-c: P < 0.01. Group 5: a-bc, a-cd, a-d, b-d, bc-d: P < 0.001; b-cd: P < 0.01; a-b: P < 0.05.

Figure 1. Rat testis. a. Group 1 (bar = 50 µm); b. group 2, degeneration (long arrow) and necrosis (thick arrow) (bar =
100 µm); c. group 3 (bar = 50 µm); d. group 4 (bar = 100 µm); e. group 5 (bar = 100 µm).

3.4. Immunohistochemical results
TGF α release was found only in Leydig cells in all
groups. Regarding intergroup comparison, there was an
intense and cytoplasmic reaction in group 1, slight and
cytoplasmic reaction in group 2, mild and cytoplasmic
reaction in group 3, and intense and cytoplasmic reaction
in groups 4 and 5 (Figure 2).
TGF β immunoreactivity was observed in Leydig cells,
spermatids, and spermatozoa in all groups. When groups
were compared according to their reaction rates, there
was intense and cytoplasmic reaction in Leydig cells and
intense cytoplasmic and nuclear reaction in spermatids
and spermatozoa of group 1; slight and cytoplasmic
reaction in Leydig cells and slight cytoplasmic and nuclear
reaction in spermatids and spermatozoa of group 2; 1
intense and cytoplasmic reaction in Leydig cells and

intense cytoplasmic and nuclear reaction in spermatids
and spermatozoa of groups 3, 4, and 5 (Figure 3).
4. Discussion
Streptozotocin (STZ), structurally a nitrosourea derivative,
is an antibiotic derived from Streptomyces achromogenes
(15). The STZ-induced diabetic rodents exhibited frequent
abnormal architectural changes in the seminiferous tubule
lined by spermatogenic cell series, Sertoli cells, and Leydig
cells, which leads to a decrease in plasma testosterone
levels (16,17) and testicular atrophy (18).
Male infertility is a common threat nowadays, and it
has increased rapidly because of hyperglycemia (11,19).
The testes of diabetic animals showed frequent abnormal
histology, and seminiferous epithelium cytoarchitecture as
well as the occludin distribution pattern appeared altered.
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Figure 2. TGF α immunoreactivity in rat testis. a. Group 1; b. group 2; c. group 3; d. group 4; e. group 5, Leydig cell (arrow)
(bar = 50 µm).

Figure 3. TGF α immunoreactivity in rat testis. a. Group 1; b. group 2; c. group 3; d. group 4; e. group 5, Leydig cell (arrow head),
spermatid (long arrow), spermatozoon (thick arrow) (bar = 50 µm).

Early occurrence of diabetes increased the percentage of
animals with a high number of damaged tubules (16).
Hassan et al. (20) reported there was germ cell depletion
of the seminiferous epithelium and malorientation of
spermatids. Some tubules showed greatly thickened walls
and the lumen diameter had increased. The interstitial
tissues appeared to have an increased area in the diabetic
group. Results of our study agreed with results of these

54

previous studies. Our study indicated abnormal histology
and necrosis in seminiferous tubules, Sertoli cells, and
spermatogenetic cells in diabetic rats, and administration
of ALA and vitamin C decreased these abnormal changes.
A decrease in body weight was observed in the STZtreated group during the experiment period (21). In our
study, a significant decrease in body weight in the diabetesinduced group was also detected.
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ALA can improve insulin sensitivity, accelerate recovery
of pancreatic β-cells, and restore the metabolic alterations
associated with diabetes (22). Packer et al. (22) reported that
ALA increases glucose uptake through translocation of the
glucose transporter to plasma membranes, a mechanism that
is shared with insulin-stimulated glucose uptake. Moini et al.
(23) reported that an insulin receptor is a potential cellular
target for ALA action, with the mechanism of action of ALA
as an insulin sensitizer. This mechanism occurs through
auto-phosphorylation of insulin receptors and oxidation of
thiol groups present in insulin receptor β-subunits by the
oxidized form of ALA, which may be required for insulinstimulated glucose transport. Moreover, administration of
ALA to streptozotocin-induced diabetic rats was reported
to lower fasting glucose levels (5). Our study indicated that
ALA has an effective protective role in diabetic rats, as ALA
decreased blood glucose levels of streptozotocin-induced
diabetic animals.
Vitamin C is a major antioxidant that is essential for
scavenging of toxic ROs in both blood and tissues (24).
Vitamin C was reported to reduce blood glucose levels in
type I diabetes (25). At the same time, vitamin C infusion
increases the body’s glucose utilization by enhancing
absorption of glucose in both healthy and diabetic
individuals (26). Compared to the diabetes control group
in our study, vitamin C supplementation in diabetic groups
decreased blood glucose levels and increased secretion of
TGF α and TGF β, which help eliminate the negative effects
of diabetes on liver tissue and have antioxidant properties.

No study has been found regarding the effects of
antioxidant administration on TGF α and TGF β secretion
in testicular tissue in diabetes. Immunolocalization
studies in testicular tissue have indicated that Leydig cells
express signiﬁcant amounts of TGF α (27,28). Teerds et al.
(28) localized TGF α by immunohistochemistry in adult
Leydig cells in the rat. Millena et al. (29) reported that LH
induces the expression of TGF α and EGFR in immature
rat Leydig cells, which, in turn, may exert autocrine effects
on steroidogenesis in Leydig cells. Furthermore, TGF βs
modulate paracrine/autocrine actions (30). Similar to
the above-mentioned studies, our study found that TGF
α was being secreted from Leydig cells and TGF β2 from
Leydig, spermatids, and spermatozoa cells. Secretion was
reduced in the diabetes-induced group; however, vitamin
C and ALA administration increased TGF α and TGF β2
secretion.
Diabetes may develop as a result of a metabolic
problem but also may occur as a result of free radical
damage to the organism. With an antioxidant defense
system, the deleterious effects of free radicals are
eliminated or minimized. We think that ALA and vitamin
C supplementation in order to reduce or eliminate the
oxidant effect in streptozotocin-induced diabetic rats
increases TGF α and TGF β2 secretions, which have
growth, development, and regulatory roles in the organism
and, therefore, can help to eliminate the negative effects of
diabetes, such as infertility, on testicular tissue.
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